nDatalyze Advances Mental Health with Genetic Insights
Company Announcements

nDatalyze Advances Mental Health with Genetic Insights

Story Highlights

nDatalyze Corp (TSE:NDAT) has released an update.

nDatalyze Corp. has provided an update on its clinical study, highlighting the importance of understanding the genetic and environmental interplay in mental health issues to enhance treatment efficacy. In addition, the company’s Mindbalanced operations have adopted a franchise-style model, integrating DNA data and TMS treatments to personalize mental health care.

For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdesknDatalyze Corp. Unveils Promising Clinical Study Outcomes
TipRanks Canadian Auto-Generated NewsdesknDatalyze Corp Announces Presidential Leadership Change
TipRanks Canadian Auto-Generated NewsdesknDatalyze Corp Reactivates OTCQB Listing in the US
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App